SYSTEMATIC REVIEW
Accepted on 08 Jul 2025
Efficacy and safety of lenvatinib plus transarterial chemoembolization with or without programmed death-1 inhibitors in the treatment of intermediate or advanced hepatocellular carcinoma: A systematic review and meta-analysis
doi 10.3389/fimmu.2025.1586914
- 171 views